LMR Partners’s CureVac CVAC Stock Holding History

LMR Partners’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60,000	Closed	-$253K	–	1187
2023 Q4	$253K	Hold	60,000	–	–	﹤0.01%	719
2023 Q3	$410K	Buy	+60,000	New	+$530K	﹤0.01%	576

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

LMR Partners's CVAC Position: Q1 2023 in Review

LMR Partners sold out of CureVac (CVAC) in Q1 2023, closing a stake of 109,360 shares — an estimated $659K sold.

LMR Partners first reported a position in CVAC in Q4 2022 and held it in 1 quarter. The position peaked at $659K in Q4 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

LMR Partners reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
LMR Partners sold 109,360 CureVac shares in Q1 2023, an estimated $659K.
LMR Partners first reported a position in CureVac in Q4 2022 and held it in 1 quarter.
LMR Partners's CureVac position peaked at $659K in Q4 2022.
82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.